ID.1
Item
males and females
boolean
ID.2
Item
age 40-60 years
boolean
ID.3
Item
bmi< or = 35 kg/m2
boolean
ID.4
Item
diabetic subjects with hba1c concentrations of < or = 8%.
boolean
ID.5
Item
diabetic subjects will be either on diet and lifestyle therapy alone, or monotherapy with metformin or sulphonylureas (except glyburide).
boolean
ID.6
Item
all diabetic subjects should be on stable dose oral agent therapy for 3 months prior to enrollment.
boolean
ID.7
Item
subjects with cerebrovascular or peripheral vascular disease.
boolean
ID.8
Item
subjects with suspected or overt autonomic neuropathy.
boolean
ID.9
Item
diabetic subject on thiazolidinediones, insulin, glp-1 based therapies (exenatide or sitagliptin), alpha-glucosidase inhibitors, glyburide or combination antidiabetic drug therapies.
boolean
ID.10
Item
diabetics with microalbuminuria.
boolean